Literature DB >> 15480172

Patient-specific prompts in the cholesterol management of renal transplant outpatients: results and analysis of underperformance.

Elizabeth A Garthwaite1, Eric J Will, Cherry Bartlett, Donald Richardson, Charles G Newstead.   

Abstract

BACKGROUND: Renal transplant recipients have an increased risk of cardiovascular disease compared with age- and gender-matched controls. It is recommended that "high-risk" patients are treated with hydroxymethylglutaryl CoA reductase inhibitors to reduce cholesterol levels.
METHOD: We evaluated the effect of a computer-based decision support algorithm in delivering patient-specific prompts to manage cholesterol in renal transplant outpatients. Data were analyzed retrospectively for a 2-year period with attention to changes in cholesterol levels, prescribing patterns of statins, and causes of underperformance.
RESULTS: At baseline, 36.7% of patients achieved a total serum cholesterol level less than 5.0 mmol/L, compared with 67.2% at 2 years, with mean values of 5.6+/-0.1 mmol/L and 4.8+/-0.1 mmol/L (P<0.0001). At baseline, 24% of the patients were receiving statin therapy, increasing to 61% at 2 years. There were no significant changes in creatinine phosphokinase, trough cyclosporine levels, or total cyclosporine dose. Alkaline phosphatase levels increased (166.1+/-3.6-184.6+/-6.1 mmol/L, P=0.009), but remained within the normal clinical range; creatinine clearance increased (58.6+/-1.0-61.0+/-1.2 mL/min, P=0.05). For patients followed concurrently in two units without the algorithm, serum cholesterol measurements decreased from 5.57 mmol/L and 5.34 mmol/L to 5.31 mmol/L and 5.27 mmol/L, respectively (P=0.05), both higher than that achieved contemporaneously at St. James's. Underperformance depended less on medical noncompliance than with systematic features of the methodology and patient preference/collaboration with treatment.
CONCLUSIONS: The introduction of the algorithm coincided with a significant reduction in cholesterol levels, an increase in the number of patients receiving appropriate therapy, and no serious adverse effects. Our results illustrate the positive effect of computer-generated prompts and decision support software.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480172     DOI: 10.1097/01.tp.0000137340.22880.c8

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  User centered clinical decision support tools: adoption across clinician training level.

Authors:  L J McCullagh; A Sofianou; J Kannry; D M Mann; T G McGinn
Journal:  Appl Clin Inform       Date:  2014-12-17       Impact factor: 2.342

2.  Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials.

Authors:  Jonathan Austrian; Felicia Mendoza; Adam Szerencsy; Lucille Fenelon; Leora I Horwitz; Simon Jones; Masha Kuznetsova; Devin M Mann
Journal:  J Med Internet Res       Date:  2021-04-09       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.